why choose us

First received: July 01, 2024

Clinical Trial: A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the Body

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Overweight

Study Type: INTERVENTIONAL


Official Title: Safety, Tolerability and Pharmacokinetics Study of Multiple Rising Subcutaneous Doses of Survodutide in Chinese Participants With Overweight or Obesity (BMI 24.0 to 40.0 kg/m2) (Non-randomization

Brief Summary: This study is open to Chinese adults aged 18 to 60 with overweight or obesity.People can join the study if they have a Body Mass Index from 24 to 40.0 kg/m2.Survodutide is a medicine being developed to help people with overweight or obesity.The purpose of this study is to find out how different doses of survodutide are taken up in the body.Other goals are to test if participants can tolerate different doses of survodutide and whether survodutide helps people with overweight or obesity.Participants receive…

Read more